Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Arcturus Therapeutics Holdings Inc
Revenue
Arcturus Therapeutics Holdings Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
|
Revenue
$166.8m
|
CAGR 3-Years
160%
|
CAGR 5-Years
60%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$28.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
Arcturus Therapeutics Holdings Inc
Revenue Breakdown
Breakdown by Geography
Arcturus Therapeutics Holdings Inc
Breakdown by Segments
Arcturus Therapeutics Holdings Inc
Total Revenue:
166.8m
USD
|
Collaboration Revenue:
157.7m
USD
|
See Also
What is Arcturus Therapeutics Holdings Inc's Revenue?
Revenue
166.8m
USD
Based on the financial report for Dec 31, 2023, Arcturus Therapeutics Holdings Inc's Revenue amounts to 166.8m USD.
What is Arcturus Therapeutics Holdings Inc's Revenue growth rate?
Revenue CAGR 5Y
60%
Over the last year, the Revenue growth was -19%. The average annual Revenue growth rates for Arcturus Therapeutics Holdings Inc have been 160% over the past three years , 60% over the past five years .